At Kielo Research, my focus as a Senior Research Associate encompasses championing patient involvement in the drug development pathway, particularly within the realm of rare diseases. Our team's dedication to integrating the patient voice into drug development processes is not only a professional commitment but a personal passion.Leveraging from my clinical experience working direcly with patients and my work in the field of patient preferences, my efforts contribute to the creation of patient-informed study designs and the selection of patient-centric outcomes. This mission aligns with my active role in the PREFER Experts Network, where we facilitate patient preferences as a cornerstone of clinical research.
-
Associate DirectorKielo ResearchYork, Gb -
Senior Research AssociateKielo Research Jan 2024 - PresentYork, England, United Kingdom -
Research Associate IiiEvidera Mar 2020 - Dec 2023Scientific project manager for multiple studies within the Patient-centred Research Team (PCR) at Evidera ensuring all projects on my care are delivered within time and budget while still honouring the highest scientific standards. Main focus areas remain rare diseases and the variety of methods that can ensure patients voice and experience informs decision making in the drug development process. High interest in patient informed protocol design, patient informed development and selection of outcome measures and patient engagement and advocacy. -
Clinical Project Lead For The Imi Prefer ProjectNewcastle University Oct 2017 - May 2021Newcastle Upon Tyne, United KingdomClinical Project Lead for the first large scale multinational patient preference study in Myotonic Dystrophy and Mitochondrial Myopathies. Three patient preference methods being tested among patients and caregivers. -
Clinical Research AssociateNewcastle University Sep 2014 - Oct 2017Newcastle Upon Tyne, United KingdomUK's site Lead Investigator for the international multicentre trial of OPTIMISTIC for Myotonic Dystrophy type 1. -
Expert Clinical Consultant And Site TrainerIpsen Innovation France Jan 2012 - Jun 2014France-UkResponding directly to the Medical Director; lead support on the planning, development and delivery of the Phase 3 Clinical Trial. -
Lead Iat SiteIpsen Jun 2010 - Dec 2011Celaya,Gto. Mexico.Contributed to a research program covering the effects of the botulinum toxin on children with paralysis and evaluated the impact of this on child development
Cecilia Jimenez-Moreno, Phd Education Details
-
Human/Medical Genetics -
Neuromuscular Diseases -
Clinical Trials -
Physical Therapy/Therapist
Frequently Asked Questions about Cecilia Jimenez-Moreno, Phd
What company does Cecilia Jimenez-Moreno, Phd work for?
Cecilia Jimenez-Moreno, Phd works for Kielo Research
What is Cecilia Jimenez-Moreno, Phd's role at the current company?
Cecilia Jimenez-Moreno, Phd's current role is Associate Director.
What schools did Cecilia Jimenez-Moreno, Phd attend?
Cecilia Jimenez-Moreno, Phd attended Newcastle University, Newcastle University, London School Of Hygiene And Tropical Medicine, U. Of London, Universidad Del Valle De México.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial